Computational simulations of local vascular heparin deposition and distribution

被引:51
作者
Lovick, MA [1 ]
Edelman, ER [1 ]
机构
[1] HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT INTERNAL MED, CARDIOVASC DIV, BOSTON, MA 02115 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1996年 / 271卷 / 05期
关键词
drug delivery; diffusion; binding; artery; model;
D O I
10.1152/ajpheart.1996.271.5.H2014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Local vascular drug delivery systems provide elevated concentrations in target arterial tissues while minimizing systemic side effects; however, definition of their precise pharmacokinetics remains elusive. The standard labeled tracer assays used in experimental vascular pharmacokinetic studies of these systems are limited because they quantify the arterial average drug concentration as opposed to transmural concentration profiles, require many animal experiments to elucidate the time-varying deposition, and track label rather than intact biologically active drug. In this study, computational simulations of drug deposition and distribution in vascular tissues after release from these systems have provided two important insights. First, simulations of arteries that were uniformly loaded with heparin predicted that most of the drug is cleared in <1 h, illustrating the need for sustained modes of delivery. Second, some of the limitations of labeled tracers can be over come by combining experimental data with simulations that provided high spatial resolution. This enabled us to describe the kinetics of the deposited drug and distinguish soluble from reversibly bound and internalized drug within cells. The latter can help differentiate biologically viable drug from its committed inactive form or metabolites. These points have been illustrated through simulations of a novel endovascular hydrogel heparin-delivery system that has been applied to the porcine coronary artery, The basic models used in these simulations are generalized, and with the appropriate boundary conditions, binding and distribution constants can be used to study the physical interactions between any compound and tissue.
引用
收藏
页码:H2014 / H2024
页数:11
相关论文
共 31 条
  • [1] [Anonymous], STRUCTURE FUNCTION C
  • [2] [Anonymous], BASIC HEMODYNAMICS I
  • [3] BRATZLER RL, 1975, ATHEROSCLEROSIS META, P943
  • [4] THE HEPARIN-BINDING (FIBROBLAST) GROWTH-FACTOR FAMILY OF PROTEINS
    BURGESS, WH
    MACIAG, T
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 : 575 - 606
  • [5] MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS
    CARDIN, AD
    WEINTRAUB, HJR
    [J]. ARTERIOSCLEROSIS, 1989, 9 (01): : 21 - 32
  • [6] REGULATION OF VASCULAR SMOOTH-MUSCLE CELL-GROWTH BY HEPARIN AND HEPARAN SULFATES
    CASTELLOT, JJ
    WRIGHT, TC
    KARNOVSKY, MJ
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (04) : 489 - 503
  • [7] EFFECT OF HEPARIN ON VASCULAR SMOOTH-MUSCLE CELLS .1. CELL-METABOLISM
    CASTELLOT, JJ
    COCHRAN, DL
    KARNOVSKY, MJ
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 124 (01) : 21 - 28
  • [8] BINDING AND INTERNALIZATION OF HEPARIN BY VASCULAR SMOOTH-MUSCLE CELLS
    CASTELLOT, JJ
    WONG, K
    HERMAN, B
    HOOVER, RL
    ALBERTINI, DF
    WRIGHT, TC
    CALEB, BL
    KARNOVSKY, MJ
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 124 (01) : 13 - 20
  • [9] CULTURED ENDOTHELIAL-CELLS PRODUCE A HEPARIN-LIKE INHIBITOR OF SMOOTH-MUSCLE CELL-GROWTH
    CASTELLOT, JJ
    ADDONIZIO, ML
    ROSENBERG, R
    KARNOVSKY, MJ
    [J]. JOURNAL OF CELL BIOLOGY, 1981, 90 (02) : 372 - 379
  • [10] CONTRASTING EFFECTS OF THE INTERMITTENT AND CONTINUOUS ADMINISTRATION OF HEPARIN IN EXPERIMENTAL RESTENOSIS
    EDELMAN, ER
    KARNOVSKY, MJ
    [J]. CIRCULATION, 1994, 89 (02) : 770 - 776